Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Peppermint Raises $4.7M to Bring Scientific Precision to the Finances of Clinical Research
Company’s AI-Powered Platform was Purpose-Built for Clinical Trial Teams and Hospital Systems to Transform Clinical Research Into a Scalable Engine for Financial Growth and Scientific Discovery
Peppermint, an AI-powered platform that streamlines financial operations and accelerates growth for clinical research teams, today announced $4.7 million in seed funding led by Moxxie, with participation from Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, Night Capital, and angel investors Benjamin Mann and Evan Moore. The funding will further enable the founding team, who previously built payments and reconciliation infrastructure for Robinhood, to transform clinical research into a scalable engine for financial growth and scientific discovery.
Despite advances in the science and technology driving novel drug development, the industry still relies on an antiquated and fragmented financial framework. Instead of payments flowing smoothly between sponsors, CROs, health systems, and research sites, clinical research relies on a patchwork of systems that were never designed to work together. Every party absorbs the cost of that complexity. Health systems carry it across an entire research portfolio, where the finances of clinical research remain one of the least visible lines on the balance sheet. Sites feel it most acutely: One-third of sites have more than 90 days’ worth of overdue receivables, and 50% of sites have three months or less of operating capital, according to a 2024 survey by the Society for Clinical Research Sites (SCRS).
Peppermint is the first AI-powered financial operations platform designed exclusively for clinical research, bringing the uncompromising precision and auditable accuracy of clinical science to its own revenue cycle.
Co-Founders David Freeman and VJ Thurimella met at X1, where they were the respective first business hire and first engineer. Together, they helped build the financial infrastructure behind the consumer credit card business that Robinhood acquired to launch its Gold Card. When they saw the inefficiency of financial systems behind clinical research – and how it was depriving research teams of not only cash, but visibility into how much a study actually generates in revenue, how much it costs to run, and the metrics behind both – they knew their fintech experience could break open the industry’s financial black box.
“At X1 and Robinhood we helped build systems designed for precision and scale, to process billions of dollars every year,” said Freeman…
Full release here, originally announced October 8th, 2026.
Vinyl Health Raises $2M from HealthX Ventures to Help Patients Record, Understand, and Share Their Care
New Personal Health Assistant Puts Patients in Control of Their Health Story While Helping Families and Care Teams Stay Connected
Vinyl Health, a patient-first health technology company using ambient AI to help people record, understand, and share their own health information, today announced $2 million in seed funding led by HealthX Ventures. The funding will support Vinyl’s broader public launch and continued development of its personal health assistant, now available in the Google Play Store and Apple’s App Store.
Navigating healthcare is increasingly difficult for patients and families. Information is often scattered across portals, printouts, visit summaries, referrals, family text chains, and memory. Vinyl helps people bring that information into one place. In addition to recording health visits and voice notes, people can pull health records from connected providers into Vinyl, creating a fuller picture of their care. Vinyl uses carefully calibrated AI tools to make sense of what happened and what comes next, while making it easy to share the right details with providers, bring loved ones in to help navigate care, and organize support from a wider circle of friends and family who want to help.
Vinyl was dreamed up by Dr. Kaitlan Baston, a national leader in integrated care and former New Jersey health commissioner and hospital CEO, to empower patients to better understand their health care and reduce the burden on patients and their loved ones.
“Patients are expected to make important decisions about their health, but they often leave appointments or hospitalizations without a clear understanding of what happened or what to do next,” said Dr. Kaitlan Baston, CEO at Vinyl Health…
Full release here, originally announced October 20th, 2026.
No comments:
Post a Comment